Home Data Calendar Blog

FATE

Tables

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Common Stock Value 0.110.100.100.100.100.100.100.100.100.100.100.090.090.090.090.090.080.080.070.070.070.070.070.050.050.050.040.040.040.040.030.030.030.030.030.030.020.020.00NANA0.00NANANA
Weighted Average Number Of Diluted Shares Outstanding 101.10NANANA98.05NANA96.70NANANA94.33NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 101.10NANANA98.05NANA96.70NANANA94.33NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Earnings Per Share Basic -0.47-0.45-0.46-0.54-0.19-0.58-0.86-0.79-0.68-0.72-0.45-0.58NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Earnings Per Share Diluted -0.47-0.45-0.46-0.54-0.19-0.58-0.86-0.79-0.68-0.72-0.45-0.58NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Revenue From Contract With Customer Excluding Assessed Tax 1.931.681.940.9358.9844.3614.9818.5518.4117.0714.2213.4111.1415.907.565.462.522.802.432.822.631.661.031.031.031.031.031.031.031.031.031.031.321.081.030.330.000.000.210.290.470.640.531.080.42
Revenues 1.931.681.940.9358.9844.3614.9818.5518.4117.0714.2213.4111.1415.907.565.462.522.802.432.822.631.661.031.031.031.031.031.031.031.031.031.031.321.081.030.330.000.000.210.290.470.640.531.080.42
Operating Expenses 52.9949.7553.2263.5087.57108.78101.37101.6692.8886.4568.8560.1957.3549.3039.0534.1737.0131.8829.5526.9023.0818.4017.7220.6315.0813.2711.3710.6011.008.689.419.039.247.997.357.556.944.905.364.563.834.694.183.823.54
Research And Development Expense 32.1431.8234.2740.8865.6387.1979.8281.3172.1469.5253.1348.0244.8538.9830.6926.6729.2825.2123.2021.6317.7314.1013.6416.8211.489.898.587.937.976.236.806.786.645.435.004.864.523.033.383.072.533.403.31NANA
General And Administrative Expense 20.8617.9318.9522.6221.9421.5821.5520.3520.7416.9415.7212.1712.5010.318.357.507.736.676.355.275.354.314.083.823.603.382.792.673.032.452.612.252.602.562.352.692.421.871.981.491.301.280.86NANA
Operating Income Loss -51.07-48.08-51.28-62.56-28.59-64.42-86.39-83.11-74.47-69.38-54.62-46.78-46.21-33.40-31.49-28.71-34.49-29.08-27.12-24.08-20.45-16.74-16.69-19.61-14.05-12.24-10.34-9.57-9.97-7.65-8.39-8.00-7.92-6.91-6.33-7.22-6.94-4.90-5.15-4.27-3.36-4.04-3.65NANA
Allocated Share Based Compensation Expense 10.989.4710.1012.9010.9819.3919.4720.5419.3314.5913.5413.2512.988.767.847.246.914.584.574.393.871.781.641.491.380.900.870.970.870.820.780.790.800.480.570.740.870.390.980.110.07NANANANA
Profit Loss -48.00-44.12-45.17-52.76-18.88-56.36-83.56-76.11-65.69-68.62-43.31-55.13-45.09-53.11-58.68-28.07-33.52-28.30-26.61-23.48-19.76-16.03-16.78-19.65-14.13-12.50-10.68NANANANANANANANANANANANANANANANANANA
Net Income Loss -48.00-44.12-45.17-52.76-18.88-56.36-83.56-76.11-65.69-68.62-43.31-55.13-45.09-53.11-58.68-28.07-33.52-28.30-26.61-23.48-19.76-16.03-16.78-19.65-14.13-12.50-10.68-9.64-10.13-7.94-8.74-8.41-8.38-7.45-6.89-7.78-6.98-5.74-6.07-5.53-3.55-4.16-4.11-2.74-3.23

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Assets 569.89506.22543.79584.76630.34705.56749.35807.06858.39921.46984.571015.671045.96622.46626.44653.59321.89302.27340.21199.88220.87213.03219.9583.1693.42105.2972.6773.9585.3395.0549.3049.1858.7067.9676.4083.4849.6555.5823.04NANA11.08NANANA
Liabilities And Stockholders Equity 569.89506.22543.79584.76630.34705.56749.35807.06858.39921.46984.571015.671045.96622.46626.44653.59321.89302.27340.21199.88220.87213.03219.9583.1693.42105.2972.6773.9585.3395.0549.3049.1858.7067.9676.4083.4849.6555.5823.04NANA11.08NANANA
Stockholders Equity 426.12368.42402.78437.75477.47483.94518.00580.48633.39678.84730.33752.07790.10384.44424.37474.11219.22244.76268.04127.53145.84160.47173.9351.8365.0077.1945.7555.2163.8673.1525.3723.1330.7338.0444.9951.0745.1850.85-66.40NANA-52.83NANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Assets Current 394.38331.54364.17392.18437.89502.07535.33599.16599.08633.41693.71713.27804.32494.32496.78540.23208.25227.09305.63165.18186.43205.20213.9380.0390.62102.6070.0471.8683.4493.3247.4047.0956.5765.6574.1981.5748.2654.6519.39NANA9.79NANANA
Cash And Cash Equivalents At Carrying Value 121.3241.8733.3346.8042.0261.3382.0955.2764.74133.58129.1876.65106.41167.35349.13433.0783.3799.81249.5971.44183.03190.51183.2536.1632.9188.9543.2331.0640.6188.6137.1035.8739.4964.8172.8681.1847.8854.0419.083.404.659.095.46NANA
Short Term Investments NA273.31NANANA374.89NANANA482.33NANANANANANANANANANANANANANANANANA39.9541.693.50NANANANANANANANANANANANANANANA
Accounts Receivable Net Current 0.861.831.542.8313.5038.4810.2213.1313.858.687.3110.306.955.513.24NANANANANA0.500.50NANA0.50NANANANANANANANANANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 9.9714.5412.9011.4115.4927.3719.9717.1811.458.837.707.377.245.894.735.104.965.662.813.172.903.692.242.021.491.650.820.851.141.210.781.160.950.840.480.400.380.610.30NANA0.71NANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Property Plant And Equipment Gross NA144.46NANANA140.40NANANA108.47NANANA43.40NANANA19.94NANANA11.45NANANA7.69NANANA5.78NANANA5.63NANANA3.11NANANA2.91NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NA47.63NANANA30.38NANANA16.95NANANA11.10NANANA8.52NANANA6.33NANANA5.14NANANA4.20NANANA3.47NANANA2.30NANANA1.75NANANA
Property Plant And Equipment Net 92.1296.84101.71106.33108.59110.02109.12103.1297.8691.5374.6259.2147.9532.3120.7115.9311.9011.429.659.228.405.123.802.892.652.552.491.951.751.581.751.941.992.162.071.771.260.810.79NANA1.16NANANA
Long Term Investments 7.590.98NA7.293.914.9413.9411.9367.94100.66124.88149.5098.28NA13.23NA16.1439.44NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Assets Noncurrent 0.010.010.010.030.030.030.030.030.030.030.010.010.010.010.010.010.010.010.01NANA0.53NANA0.020.020.020.020.020.020.020.020.020.02NANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Liabilities Current 45.3739.0941.3344.6948.65114.05103.9491.5277.9181.2891.88105.6094.5885.5654.2045.3224.9227.8140.5929.4229.1427.2622.6716.2712.5911.059.728.0516.9015.1914.6814.3313.8913.4412.6011.314.354.609.49NANA4.85NANANA
Accounts Payable Current 6.764.725.717.519.868.279.598.4211.448.616.445.779.006.283.7213.565.175.825.715.415.374.215.243.512.161.682.201.182.470.931.202.001.981.001.281.511.330.68NANANA1.23NANANA
Other Accrued Liabilities Current 18.658.128.638.1110.2319.1818.9012.2913.0311.7110.807.345.745.503.813.153.243.394.452.943.593.262.632.983.402.171.531.941.751.411.270.660.751.000.781.08NA0.79NANANANANANANA
Accrued Liabilities Current 32.0427.5128.5429.4731.5153.9350.1540.5235.1142.4154.0025.7420.9315.5614.7811.6211.7714.7013.849.839.9510.939.648.387.447.255.414.774.703.963.342.352.042.442.322.491.642.04NANANA1.04NANANA
Contract With Customer Liability Current 0.160.691.111.931.7442.2335.2433.6622.5721.4823.5523.0321.0321.1417.1214.632.922.793.375.056.587.593.251.78NA2.10NANANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Operating Lease Liability Noncurrent 95.6797.3698.98100.56102.07103.71105.16106.59107.94109.24104.36105.41106.5193.9483.1678.6873.8325.23NANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Stockholders Equity 426.12368.42402.78437.75477.47483.94518.00580.48633.39678.84730.33752.07790.10384.44424.37474.11219.22244.76268.04127.53145.84160.47173.9351.8365.0077.1945.7555.2163.8673.1525.3723.1330.7338.0444.9951.0745.1850.85-66.40NANA-52.83NANANA
Common Stock Value 0.110.100.100.100.100.100.100.100.100.100.100.090.090.090.090.090.080.080.070.070.070.070.070.050.050.050.040.040.040.040.030.030.030.030.030.030.020.020.00NANA0.00NANANA
Additional Paid In Capital 1685.931580.031570.781560.681547.701536.501515.601494.641470.921448.581430.771409.211392.28941.22927.78918.53636.06628.20623.16456.00450.93445.80443.24304.37297.88295.93252.02250.82249.82248.96NANANANA179.90179.10138.65137.3414.37NANA12.79NANANA
Retained Earnings Accumulated Deficit -1259.74-1211.73-1167.61-1122.44-1069.68-1050.80-994.44-910.88-834.77-769.08-700.46-657.15-602.02-556.93-503.82-445.14-417.06-383.55-355.24-328.63-305.16-285.40-269.37-252.59-232.93-218.80-206.30-195.62-185.97-175.85-167.91-159.17-150.76-142.38-134.94-128.05NA-86.51NANANANANANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -0.190.01-0.50-0.59-0.65-1.85-3.25-3.38-2.85-0.76-0.07-0.09-0.260.070.310.620.140.020.050.09NA-0.00-0.01-0.01-0.01-0.00-0.01-0.04-0.03-0.00NANANANANANANANANANANANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 10.98NA10.1012.9010.98NA19.4720.5419.33NA13.5413.2512.98NA7.847.246.91NA4.574.393.87NA1.641.491.38NA0.870.970.87NANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Net Cash Provided By Used In Operating Activities -33.35-36.64-38.27-28.49-28.86-75.39-55.05-53.16-64.61-70.29-33.38-32.11-27.10-20.66-30.7338.84-26.67-25.54-19.84-20.31-17.49-11.02-3.56-11.52-12.55-10.72-9.77NANANANANANANANANANANANANANANANANANA
Net Cash Provided By Used In Investing Activities 17.3145.3524.8033.179.3453.1180.3840.29-7.0371.2877.96-1.37-471.89-166.03-54.1435.3223.77-110.5236.29-91.988.7516.3813.2813.72-43.8413.2013.64NANANANANANANANANANANANANANANANANANA
Net Cash Provided By Used In Financing Activities 95.49-0.180.000.060.211.521.493.412.803.427.943.72438.054.910.93275.551.45-13.72161.710.691.261.90137.371.160.3543.248.30NANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Net Cash Provided By Used In Operating Activities -33.35-36.64-38.27-28.49-28.86-75.39-55.05-53.16-64.61-70.29-33.38-32.11-27.10-20.66-30.7338.84-26.67-25.54-19.84-20.31-17.49-11.02-3.56-11.52-12.55-10.72-9.77NANANANANANANANANANANANANANANANANANA
Net Income Loss -48.00-44.12-45.17-52.76-18.88-56.36-83.56-76.11-65.69-68.62-43.31-55.13-45.09-53.11-58.68-28.07-33.52-28.30-26.61-23.48-19.76-16.03-16.78-19.65-14.13-12.50-10.68-9.64-10.13-7.94-8.74-8.41-8.38-7.45-6.89-7.78-6.98-5.74-6.07-5.53-3.55-4.16-4.11-2.74-3.23
Profit Loss -48.00-44.12-45.17-52.76-18.88-56.36-83.56-76.11-65.69-68.62-43.31-55.13-45.09-53.11-58.68-28.07-33.52-28.30-26.61-23.48-19.76-16.03-16.78-19.65-14.13-12.50-10.68NANANANANANANANANANANANANANANANANANA
Depreciation Depletion And Amortization 4.824.884.744.474.194.843.192.962.762.211.521.170.960.860.770.750.700.620.590.540.440.330.310.280.290.290.240.230.210.200.220.230.230.210.190.160.120.130.140.140.160.16NANANA
Increase Decrease In Accounts Receivable -0.970.29-1.30-10.67-24.9828.26-2.90-0.725.171.36-2.993.361.432.271.53NANA0.000.00NANA0.00NANANANANANANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Net Cash Provided By Used In Investing Activities 17.3145.3524.8033.179.3453.1180.3840.29-7.0371.2877.96-1.37-471.89-166.03-54.1435.3223.77-110.5236.29-91.988.7516.3813.2813.72-43.8413.2013.64NANANANANANANANANANANANANANANANANANA
Payments To Acquire Property Plant And Equipment 0.090.180.562.203.216.688.6810.1310.0818.3714.7313.623.982.270.950.641.072.591.261.791.751.120.720.280.180.800.360.410.150.040.030.210.180.180.660.210.400.150.020.060.010.29NANANA
Payments To Acquire Investments 86.3349.97102.1392.26114.45107.10101.5863.95132.17173.45165.4799.34529.91185.01NANANA142.68NANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Net Cash Provided By Used In Financing Activities 95.49-0.180.000.060.211.521.493.412.803.427.943.72438.054.910.93275.551.45-13.72161.710.691.261.90137.371.160.3543.248.30NANANANANANANANANANANANANANANANANANA

    2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Revenues 1.931.681.940.9358.9844.3614.9818.5518.4117.0714.2213.4111.1415.907.565.462.522.802.432.822.631.661.031.031.031.031.031.031.031.031.031.031.321.081.030.330.000.000.210.290.470.640.531.080.42
Janssen Biotech Inc NA0.000.000.0052.3031.4014.2018.1015.9013.0011.2010.908.607.705.603.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Ono Pharmaceutical Company Ltd 1.901.701.900.906.7012.900.800.402.504.003.002.502.508.101.902.002.502.802.402.501.60NANANANANANANANANANANANANANANANANANANANANANANANA
Janssen Biotech Inc, Research And Development Expense NA0.000.000.0011.1011.1010.0011.409.808.507.107.106.806.202.401.70NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Janssen Biotech Inc, Upfront Fee And Equity Premium NA0.000.000.0031.206.004.206.706.104.504.103.801.801.503.201.80NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Commercial Option Exercise NA0.000.009.990.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Excluding Assessed Tax 1.931.681.940.9358.9844.3614.9818.5518.4117.0714.2213.4111.1415.907.565.462.522.802.432.822.631.661.031.031.031.031.031.031.031.031.031.031.321.081.030.330.000.000.210.290.470.640.531.080.42
Janssen Biotech Inc NA0.000.000.0052.3031.4014.2018.1015.9013.0011.2010.908.607.705.603.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Ono Pharmaceutical Company Ltd 1.901.701.900.906.7012.900.800.402.504.003.002.502.508.101.902.002.502.802.402.501.60NANANANANANANANANANANANANANANANANANANANANANANANA
Janssen Biotech Inc, Research And Development Expense NA0.000.000.0011.1011.1010.0011.409.808.507.107.106.806.202.401.70NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Janssen Biotech Inc, Upfront Fee And Equity Premium NA0.000.000.0031.206.004.206.706.104.504.103.801.801.503.201.80NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Commercial Option Exercise NA0.000.009.990.01NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Balance Sheet
Liabilities Current
Assets
Operating Lease Right Of Use Asset
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Liabilities Current
Current Liabilities
Contract With Customer Liability Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept